1st Quarter - Amendment
PODESTA GROUP, INC. for GENZYME
Firm
Client
Income
$60,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 22, 2013 | $60,000 | Replaced |
| 1st Quarter - Amendment (this page) | Sep 25, 2014 | $60,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
340B issues. Patient Protection and Affordable Care Act (implementation). Health Care and Education Reconciliation Act of 2010 (implementation).
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| ANTHONY PODESTA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.